With Pfizer’s revenue and share price slumping after the drugmaker skyrocketed to new heights during the pandemic, the ...
Health insurance companies are expected to pull back slightly from Medicare Advantage investing in 2025. Instead, Modern Healthcare reports, they will focus on Dual-Eligible Special Needs Plans, or ...
KEY TAKEAWAYS Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Meanwhile, even as Pfizer’s stock price has sagged and eroded investor wealth, PFE boasts an attractive dividend yield, which currently stands at 5.75%. Could this overlooked dividend stock finally ...
Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...
(Reuters) - Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday ...
Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...
A federal judge ordered the tech giant to let rival app stores onto its Android smartphone platform, adding to its growing ...
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...